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Abstract 
Objective: This study examined the associations between gait variability based on common spatiotemporal 
parameters and energetic cost of walking in persons with multiple sclerosis. 
Design: Eighty-six persons with multiple sclerosis underwent the 6-min walk while wearing a portable 
metabolic unit. The cost of walking was generated by dividing the net steady-state VO2 (milliliter per kilogram 
per minute) by walking speed during the 6-min walk. Participants further completed two trials of walking on 
the GAITRite mat at a self-selected pace for measuring spatiotemporal parameters. Variability of step length, 
step time, stride length, swing time, stance time, stride velocity, and single- and double-support time was 
indexed by the coefficient of variation. 
Results: Variability in the spatiotemporal variables and Expanded Disability Status Scale scores were 
significantly correlated with cost of walking (i.e., [rho] = 0.25-0.36). Multivariate analysis revealed that 
disability (Expanded Disability Status Scale: [beta] = 0.186), stance time variability ([beta] = 1.446), and step 
length variability ([beta] = -1.216) explained significant variance (R2 = 0.38, P < 0.001) in cost of walking. 
Conclusions: We provide evidence of the positive association between gait variability and cost of walking 
during overground walking in persons with multiple sclerosis. The findings highlight the need for interventions 
aiming to reduce gait variability, thereby reducing the energetic demands of walking in this population. 
 
There is evidence that the energetic cost of walking (Cw), defined as the amount of oxygen consumed per 
kilogram of body weight per unit distance traveled,1 is higher in persons with multiple sclerosis (MS) 
compared with healthy controls.2 The higher Cw may be associated with gait impairment in MS.3 We are 
aware of one study that reported significant inverse correlations between gait speed and stride length with 
Cw and a positive correlation between double-limb support and Cw in persons with MS.4 Persons who walked 
with slower velocity, had shorter strides, and spent more time with both feet on the ground (i.e., double-limb 
support) spent more energy when walking. 
Previous studies examining the associations between gait parameters and Cw in MS have focused on mean 
values of gait parameters but have not considered measures of gait variability (i.e., the stride-to-stride 
fluctuations in walking).4 This is important because individual variability in kinematic variables is considered 
an index of movement consistency or stability.5 Gait variability further offers a complementary way of 
quantifying walking and its changes with the disease. Gait variability represents a way of monitoring the 
impact of interventions and rehabilitation and the effects on other physiological systems (i.e., cardiovascular). 
Of note, one study using treadmill walking suggested that increased step variability may contribute to 
increased Cw in young, healthy individuals without MS or other disease.6 Another study compared the gait 
mechanics and metabolic cost in 10 healthy adults during treadmill walking with and without external 
stabilization.7 This study demonstrated that lower foot placement variability associated with external 
stabilization was accompanied by modest but significant decreases in metabolic Cw. We believe that exploring 
gait variability and its association with Cw may identify potential intervention targets of rehabilitation 
programs focusing on reducing energy expenditure during walking in persons with MS. If successful, targeting 
gait variability may improve walking efficiency, which may have a positive impact on participation and fatigue 
in MS. 
The present study examines the associations between variability in common spatiotemporal gait parameters 
(i.e., step time, step length, stride length, stride time, swing time, stance time, single- and double-support 
time) and Cw in persons with MS. Based on results from previous work,6 we hypothesized that metrics of 
spatiotemporal gait variability would be associated with Cw in persons with MS such that larger amounts of 
variability during gait would yield higher Cw. 
METHODS 
Participants 
This cross-sectional study used secondary outcomes from a baseline testing session of a behavioral 
intervention for increasing physical activity in persons with MS.8 Participants were contacted (a) by mail 
through a flyer that was sent to patients in North American Research Committee on Multiple Sclerosis registry 
or (b) by e-mail through a flyer that was sent to participants in a database from previous studies conducted in 
the laboratory for the past 5 yrs. There were 511 participants who initially expressed interest and who were 
contacted via phone by the project coordinator. After explaining the study protocol, the project coordinator 
undertook screening for inclusion with 230 individuals who remained interested. The inclusion criteria 
involved (a) having a definite diagnosis of MS (i.e., physician's verification of MS diagnosis), (b) being relapse 
free for the past 30 days, (c) being able to walk with or without an assistive device (i.e., cane, crutch, or 
walker) for collection of oxygen Cw and gait outcomes, (d) between 18 and 64 yrs of age, (e) willing and able 
to travel to the laboratory to complete the walking assessments, (f) participating in less than 3 days per week 
of physical activity behavior, (g) having a low risk for contraindications of physical activity based on no more 
than a single "yes" response on the Physical Activity Readiness Questionnaire; and (h) able to provide a 
physician's approval for participation in the study. Of the 230 persons screened, 102 did not meet inclusion 
criteria, with the primary reasons being too physically active (53.7%) or unwilling to travel to our laboratory 
(21.7%); 39 additional persons did not provide physician's approval; and 3 cancelled the testing session 
because of scheduling conflicts. This resulted in a final analyzed usable data of 86 persons with MS who 
enrolled in the study. 
Measures 
Energetic Cw 
A commercially available portable metabolic unit, K4b2 (Cosmed, Rome, Italy), was used to measure breath-
by-breath oxygen consumption (VO2) during a standard 6-min walk test (6MW).9 The 6MW was performed 
overground in a well-lit and safe hallway with two 180-degree turns marked by cones separated 75 feet apart. 
The O2 and CO2 analyzers of the portable metabolic unit were calibrated using known concentrations of gases, 
and the flowmeter was calibrated using a 3-l syringe (Hans Rudolph, Kansas City, MO). VO2 (milliliter per 
kilogram per minute) was measured as 30-sec averages for 1 min both before the 6MW (i.e., resting VO2) and 
over the entire test. The total distance traveled (meter) was also measured using a measuring wheel (Stanley 
MW50, New Briton, CT). Net steady-state VO2 was calculated by (a) calculating steady-state VO2 as the 
average VO2 value across the final 3 mins of the 6MW (i.e., mins 4-6)10 and (b) subtracting resting-state 
VO2 values for the 1 min before the 6MW. The Cw was then computed by dividing net steady-state 
VO2 (milliliter per kilogram per minute) by walking speed during the 6MW (meter per minute).1 This resulted 
in Cw expressed as milliliter per kilogram per minute. 
Gait Variability 
Gait variability was determined using a 16-foot electronic walkway (GAITRite, CIR Systems, Inc, Haverton, PA). 
Participants completed two trials of walking on the GAITRite mat at a self-selected pace for measuring 
spatiotemporal parameters. Variability of step length (centimeter), step time (second), stride length 
(centimeter), swing time (second), stance time (second), stride velocity (centimeter per second), and single- 
and double-support time (second) was expressed as the coefficient of variation (CV), which is calculated as 
follows: CV = standard deviation/mean. Coefficient of variation is operationalized as a relative measure of 
variability.11 The recorded variables were averaged across both trials. A detailed description of each variable 
can be located in the technical reference manual available athttp://www.gaitrite.com. 
Procedure 
The protocol was approved by a university institutional review board, and all participants provided written 
informed consent before data collection. The protocol included a single session for collecting all data in a 
university laboratory setting. Data were collected either during the morning or in the afternoon, which best 
accommodated participants' availability. Of note, previous studies conducted with persons with MS have 
demonstrated no or very small effect of time of the day in gait parameters/variability.12,13 All participants 
initially completed a questionnaire to provide clinical and sociodemographic information. Participants then 
underwent neurological examination by a neurostatus-certified researcher for the generation of an Expanded 
Disability Status Scale (EDSS) score.14 Participants completed two trials on the GAITRite, followed by 10 mins 
of seated rest. Participants were fitted with the K4b2 portable metabolic system during the seated rest. Once 
wearing the system and after ensuring normal, resting metabolic functioning, participants were given 
standardized instructions for undertaking the 6MW and then completed the test. Participants were 
compensated US $50 for completing the session. This study conforms to all STROBE guidelines and reports the 
required information accordingly (see Checklist, Supplemental Digital Content 
1,http://links.lww.com/PHM/A596). 
Data Analysis 
All analyses were carried out using SPSS Version 22 (SPSS Inc; IBM Corp, Armonk, NY) and significance level 
was set at a P value of less than 0.05. Kolmogorov Smirnov revealed that the variables included in this study 
did not present a normal distribution. Descriptive statistics are presented as median (interquartile range), 
minimum and maximum. We further decided to present the data as means (SD) to better compare our results 
with previous work. Missing data were replaced by a sample mean using the expectation-maximization 
approach, after the missing completely at random test revealed that the missing data occurred at 
random.15 Bivariate Spearman's correlation was performed between metrics of gait variability, disability level 
(i.e., EDSS), and Cw. Values for correlation coefficients of 0.1, 0.3, and 0.5 were interpreted as small, 
moderate, and large, respectively. We further used liner regression analysis with stepwise entry to identify 
significant predictors of Cw, by including only variables significantly associated in the bivariate correlation 
analysis plus age and disease duration. Age and disease duration were included because of the large variance 
in the sample and because of its logical relationship with oxygen consumption capacity. 
RESULTS 
Demographic Characteristics 
The sample included 86 persons with MS. The majority of the sample was female (n = 66/76.7%), with an 
average age of 49.2 (SD = 8.9) yrs, and average body mass index was 28.4 (SD = 7.89) kg/m2. Nearly 78% of the 
participants presented with relapsing-remitting MS, approximately 12 (SD = 8.1) yrs of disease, and moderate 
levels of disability (EDSSmedian = 3.5, IQR = 3.25). 
Energetic Cw and Gait Variability 
The average steady-state VO2 for the sample was 13.8 (SD = 3.8) mL[middle dot]kg-1[middle dot]min-
1 and the average VO2 resting state was 3.4 (SD = 1.07) mL[middle dot]kg-1[middle dot]min-1. The net 
steady-state VO2 was 10.3 (SD = 3.7) mL[middle dot]kg-1[middle dot]min-1. During the 6MW, 
participants traveled an average of 418.6 (SD = 154.1) meters. This resulted in participants performing 
the test at an average speed of 69.7 (SD = 25.6) m/min. Using the calculations described in the 
methods section, the net Cw was 0.16 (SD = 0.09) mL[middle dot]kg-1[middle dot]min-1. Descriptive data 
of the metrics of gait and gait variability are presented in Table 1. Briefly, the mean step length was 58 
(SD = 12.9) cm and step time of 0.73 (SD = 0.65) secs. On average, participants presented with a swing 
time of 0.46 (SD = 0.30) secs and stride velocity of 99.6 (SD = 31.7) cm/sec. These values are similar to 
those observed in other sample of ambulatory persons with MS.16 
 
TABLE 1. Descriptive values of spatiotemporal metrics of gait and gait variability indexed by 
the coefficient of variability 
Parameter Mean (SD) Median (IQR) Minimum  Maximum 
Means     
Step length, cm 58.1 (12.9) 58.2 (17.5) 25.1  89.2 
Step time, sec 0.73 (0.65) 0.58 (0.11) 0.48  5.86 
Stride length, cm 116.9 (25.5) 118.1 (33.4) 50.8  178.8 
Swing time, sec 0.46 (0.30) 0.40 (0.05) 0.30  2.94 
Stance time, sec 0.87 (0.51) 0.75 (0.19) 0.61  4.69 
Stride velocity, cm/sec 99.6 (31.7) 104.0 (43.8) 9.86  160.04 
Single-support time, sec 0.46 (0.30) 0.40 (0.05) 0.30  2.94 
Double-support time, sec 0.57 (0.92) 0.36 (0.15) 0.22  7.48 
 
Coefficient of variability*     
Step length 0.09 (0.28) 0.04 (0.05) 0.01 2.66 
Step time 0.10 (0.29) 0.04 (0.04) 0.01 2.05 
Stride length 0.05 (0.05) 0.03 (0.03) 0.01 0.44 
Swing time 0.11 (0.30) 0.04 (0.03) 0.01 2.11 
Stance time 0.05 (0.06) 0.04 (0.03) 0.01 0.62 
Stride velocity 0.07 (0.11) 0.05 (0.05) 0.01 0.99 
Single-support time 0.11 (0.30) 0.04 (0.03) 0.01 2.11 
Double-support time 0.13 (0.31) 0.08 (0.06) 0.02 2.23 
*Coefficient of variability (CV = standard deviation/mean). 
 
 
TABLE 2.  Spearman rank-order correlations (ρ) between metrics of ariability (i.e., CV), disability, and 
energetic Cw in 86 persons ith MS 
 
 Cw  
Metrics of Gait Variability Correlation Coefficient 95% CI 
Step length CV 0.25* 0.04–0.43 
Step time CV 0.25* 0.04–0.43 
Stride length CV 0.25* 0.04–0.43 
Swing time CV 0.30* 0.09–0.48 
Stance time CV 0.32* 0.11–0.49 
Stride velocity CV 0.30* 0.09–0.48 
Single support CV 0.30* 0.09–0.48 
Double support CV 0.36* 0.16–0.53 
EDSS (score) 0.29* 0.08–0.47 
 
*Statistical significance at P < 0.05. 
 
 
 
TABLE 3. Significant predictors of the energetic Cw in persons with MS 
 
Model Variable Unstandardized B SE B β 
1 EDSS 0.17 0.005 0.387 
2 EDSS 0.013 0.005 0.291 
 Stance time CV 0.356 0.138 0.269 
3 EDSS 0.008 0.004 0.186 
 Stance time CV 1.911 0.349 1.446 
 Step length CV −0.380 0.080 −1.216 
Regression model was adjusted by age and years of disease. 
 Model 1: R2 = 0.15; ΔR2 = 0.15; P < 0.001. 
Model 2: R2 = 0.23; ΔR2 = 0.06; P = 0.011. 
Model 3: R2 = 0.38; ΔR2 = 0.17; P < 0.001. 
 
Bivariate correlations between metrics of gait variability, disability, and Cw are given in Table 2. Briefly, 
Spearman's rank-order rho correlations indicated that relative variability (i.e., CV) in step length, step time, 
stride length, swing-time, stance time, stride time, single- and double-support, as well as EDSS scores were 
significantly and weakly-to-moderately associated with Cw (i.e., [rho] = 0.25-0.36) (Table 2). 
The correlations conducted for the Cw and spatiotemporal metrics of gait variability were followed by linear 
regression analysis with stepwise entry to determine whether significant gait variability metrics correlates 
of Cw observed in Table 2 predicted Cw. Because age and disease duration had high variability in the sample, 
we opted to include these variables into the analysis as controlling variables. Findings from the stepwise 
linear regression analysis are given in Table 3. Briefly, disability (i.e., EDSS), stance time variability, and step 
length variability entered into the equation and explained significant variance in Cw. This indicated that 
disability level and variability in stance time and step length emerged as independent predictors of Cw in 
persons with MS (Table 3). 
 
DISCUSSION 
This study examined the associations between variability in metrics of spatiotemporal gait parameters 
(indexed by the coefficient of variability) and Cw in 86 persons with MS. All metrics of gait variability (i.e., step 
length, step time, stride length, swing time, stance time, stride velocity, and single- and double-support time) 
examined in the present study were positively associated with Cw, such that those presenting with higher 
variability had greater Cw. In addition, EDSS scores (i.e., disability level) were positively associated with Cw, 
such that those with greater disability severity (i.e., higher EDSS scores) presented with greater Cw. Further 
analysis revealed that disability severity and variability in stance time and step length emerged as significant 
predictors of Cw, explaining approximately 36% of the variance in Cw. This suggests that disability severity and 
increased variability in stance time and step length significantly contribute toward the energetic penalty of 
overground walking in persons with MS. Our results support previous research that has demonstrated the 
association between disability severity and Cw involving persons with MS.10 We are unaware of previous work 
examining gait variability and Cw in persons with MS. However, our findings that different metrics of gait 
variability are associated with Cw corroborates the results of a previous study in different populations. Of 
note, one study conducted in ambulatory persons with stroke observed that reduction in energetic cost of 
overground walking with support was accompanied by changes in temporal gait parameters such as decrease 
in stride time variability.17 Researches have further investigated the extent to which gait characteristics 
explain differences in metabolic (i.e., O2) Cw in adults with Down syndrome. The authors observed that step 
length, step width, and step time variability uniquely explain about 22% of the variance in the Cw in this 
population, with step length variability presenting with the greatest unique contribution to the variance. 
According to the authors, 75% of the excess Cw in adults with Down syndrome is due to underlying factors 
that increase center of mass mediolateral motion and the variability in their center of mass anteroposterior 
velocity, step length, and step width.18 Investigators have further observed that increased step variability was 
associated with significantly higher energy expenditure during treadmill walking in a small sample (n = 11) of 
healthy young adults.6 Similarly, investigators have observed that healthy adults walking with asymmetric 
steps time require substantial metabolic cost above those imposed by nonpreferred step times.19 Taken 
together, the findings of the present study and previous works highlight the potential key role of gait 
variability in the Cw not only in persons with MS but also in different clinical populations. 
There is evidence suggesting that stance phase dominates the Cw. For instance, researchers investigating the 
Cw using a modeling approach that allowed them to measure instantaneous energy consumption rates in 
individual muscles over the full gait cycle observed that the stance phase represented 71% of the total muscle 
energy consumption during preferred stride rate walking.20 This is consistent with our findings such that 
stance time variability moderately correlated with Cw and was a significant independent predictor of Cw in our 
sample. It is possible persons with MS who have increased gait variability spend energy not only to drive the 
center of mass during walking but also to further on movements to correct for irregular foot placement, 
requiring an extra effort (i.e., energy demand) of stability control during walking.6 This is supported by 
evidence demonstrating that persons with MS have higher energetic Cw.21 
It is believed that persons with MS have increased gait variability compared with healthy controls during 
walking and that such increased variability occurs early on in the disease and apparently worsens with 
increasing disability.22 Greater Cw during walking can have a significant impact on energy reserves of persons 
with MS, and this can have an impact on fatigue, a common symptom in persons with MS.23 Gait variability 
has been further suggested to be a more sensitive fall predictor in persons with MS with low disability than a 
disability assessment (i.e., EDSS).24 Collectively, this suggests gait variability as an important and critical 
aspect of disease to be considered in rehabilitation programs in this population. Interventions focusing on 
reducing gait variability may potentially benefit multiple aspects associated with the disease (e.g., fatigue) 
that have been associated with reduced quality of life in this population.25 Research has demonstrated that 
exercise training is effective in improving metrics of gait (such as those investigated in the present study) in 
older adults of the general population. For instance, investigators conducted a 6-mo study using a music-
based multitask exercise program requiring participants to walk in time with music or to walk while 
simultaneously handling objects or instruments. Compared with the control group, the training program led 
to improvements in outcomes such as gait velocity, stride length, stance time, and mediolateral angular 
velocity.26 Although not conducted in persons with MS, the previous provides evidence that improvements in 
gait variables such as those addressed in the present study (e.g., stride length, stance time) are possible. 
However, it is unclear whether improvements in those parameters translate to reduced variability during gait. 
Future studies should investigate whether an intervention focusing on improving aspects of gait translates 
into reduced gait variability in persons with MS and potential outcomes such as mobility. 
To our knowledge, this is the first study to examine metrics of spatiotemporal gait variability as variables 
associated with Cw in persons with MS. Previous studies have reported important and significant associations 
between mean spatiotemporal gait parameters, fatigue, daily activity, and disability status with Cw in persons 
with MS in both treadmill and overground walking.4,10,27 The novelty of the current study was the focus on 
metrics of spatiotemporal gait variability as potential correlates of Cw during overground walking in persons 
with MS to have a better understanding of whether individual gait variability affects Cw. This is important 
because there is some evidence of the clinical relevance of gait variability in persons with MS.11,24,28 
This study provided preliminary evidence of the associations between metrics of gait variability and the 
energy cost of overground walking in persons with MS, and along with the relatively large sample size (n = 
86), these could be regarded as strengths of the study. This study has some limitations. Because of the cross-
sectional nature of the study, causality cannot be established. Another limitation is the demographic and 
clinical composition of our sample, which was composed mostly by women with the relapsing-remitting 
course of the disease. Despite the sample being similar to other studies with MS,4,11,28 it is important that 
future studies investigate similar purposes in a more diverse sample with involvement of a control group. 
Future studies should further examine the effects of rehabilitation interventions addressing gait variability on 
Cw and its potential relations with activity and perception of fatigue in persons with MS. Another point to be 
considered when interpreting the findings of this study lies in the fact that we did not have data on spasticity. 
There is evidence suggesting that spasticity is associated with walking performance and gait 
variability.29,30 For instance, researchers examined the association between alterations of the motor system 
metrics and Cw in 33 persons with MS with an average age of 41 yrs. The authors observed that Cw was 
significantly associated to spasticity of the lower limbs, whereas in lower limb and truncal weakness, it did not 
contribute to higher Cw.29 More recently, Phadke et al.30 examined the effect of spasticity and cognitive dual 
task on gait variability and gait asymmetry in 43 adults with neurological disorders (7/43 with MS) with an 
average age of 52 (SD = 19) yrs. The authors observed that step length asymmetry was higher in those with 
high ankle spasticity compared with those with low ankle spasticity.30 
We demonstrated that variability in step length, step time, stride time, swing time, stance time, single-
support time, and double-support time positively correlated with Cw in the bivariate analysis. We further 
demonstrated that in the multivariate analysis, disability (i.e., EDSS scores) and variability in stance time and 
step length emerged as significant predictors of Cw in this sample. Such findings highlight the need for 
interventions targeting specific aspects of gait variability for reducing the energetic demands of walking in this 
population. Nonetheless, further studies addressing gait variability and Cw in persons with MS are needed to 
improve our understanding on this matter, which may translate to better recommendations for rehabilitation 
interventions in this population. 
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